Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e49463d75950b0aff2cda115d1f60618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8141967a2abac87f67a5dfd2d388eff4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55878d6e692d37fd2b9ec2e98510029b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 |
filingDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d430d38e83568a77ad0c52873ba5664 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6c5b36fac79c4dc448880a5129ed07 |
publicationDate |
2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013317066-A1 |
titleOfInvention |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
abstract |
Compounds useful in the treatment of mammalian cancers and especially human cancers according to Formula I are disclosed. n n n n n n n n n n Pharmaceutical compositions and methods of treatment employing the compounds disclosed herein are also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8975282-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969388-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326975-B2 |
priorityDate |
2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |